GIE Medical
Plymouth, US · Founded 2018 · 1 known investors
GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.
BiotechHealthtechMedical Devices
Founders & leadership
LW
Lixiao WangFounder & Chief Executive Officer
IS
Ian SchornChief Operational Officer
JN
James NessChief Financial Officer
HM
Harrison MalinoffVP of Operations and Quality
DH
Dave HendricksonVP of Research & Development
DM
Drew McClureVP of Market Development
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5MraisedSep 2023 · 1 investors · Other Health CareRule 506(b)
▶$5MraisedSep 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ling ShangDirector
- Hui HuDirector
- Ouyang XiangyuDirector
- Lixiao WangExecutive Officer, Director, Promoter
- Rushu LuoDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$11MraisedFeb 2021 · 33 investors · Other Health CareRule 506(b)
▶$11MraisedFeb 2021 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $32.9M
- Amount sold
- $11M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedAug 2018 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $4.1M
- Amount sold
- $2M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.